Home » Medical Devices » Vascular Grafts Market

Vascular Grafts Market By Product (Haemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery Bypass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts); By Application (Cardiac Aneurysm [Endovascular Stent Graft, Vascular Graft], Kidney Failure, Vascular Occlusion, Coronary Artery Disease, Others); By Raw Material (Synthetic Vascular Grafts, Polytetrafluoroethylene (PTFE) Grafts, Polyester Grafts, Polyurethane Grafts, Biological Vascular Grafts [Autografts, Allografts, Xenografts], Hybrid Vascular Grafts); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Vascular Grafts Market Size 2023	USD 1,263.48 Million
Vascular Grafts Market, CAGR	7.50%
Vascular Grafts Market Size 2032	USD 2,422.39 Million

Market Overview

The Vascular Grafts Market is projected to grow from USD 1,263.48 million in 2023 to an estimated USD 2,422.39 million by 2032, with a compound annual growth rate (CAGR) of 7.50% from 2024 to 2032. The market growth is driven by the increasing prevalence of cardiovascular diseases, rising demand for minimally invasive surgeries, and advancements in medical technology, particularly in graft materials and design.

Key market drivers include the surge in incidences of vascular disorders, technological innovations in graft development, and the rising demand for synthetic and biological grafts. Trends such as increased investment in healthcare infrastructure and the adoption of advanced vascular repair methods are shaping the market’s evolution. The push toward minimally invasive procedures is also gaining traction, further boosting the adoption of vascular grafts globally.

Geographically, North America holds the largest market share due to its well-established healthcare infrastructure and high prevalence of vascular diseases. Europe follows closely, driven by advancements in medical technology and an aging population. The Asia Pacific region is expected to witness the fastest growth due to rising healthcare expenditure and increasing awareness of vascular health. Key players in the market include B. Braun Melsungen AG, LeMaitre Vascular Inc., Terumo Corporation, and Medtronic plc. These companies are actively engaged in product development and strategic partnerships to strengthen their market position.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Rising Prevalence of Cardiovascular Diseases

The growing incidence of cardiovascular diseases (CVDs) is one of the primary drivers of the vascular grafts market. CVDs, including coronary artery disease, peripheral artery disease, and aneurysms, are leading causes of death globally, with the World Health Organization (WHO) estimating that nearly 17.9 million people die from CVDs each year. Factors such as sedentary lifestyles, poor dietary habits, smoking, and alcohol consumption contribute to the rising prevalence of these diseases. As these conditions often necessitate surgical interventions such as bypass surgeries or aneurysm repair, the demand for vascular grafts continues to increase. Vascular grafts are used to redirect blood flow, replace damaged vessels, or bypass blocked arteries. For patients suffering from severe CVDs, grafts provide a critical solution in ensuring blood flow to vital organs. As the prevalence of CVDs rises, healthcare providers are increasingly relying on advanced graft materials and technologies to perform successful surgeries, improving patient outcomes. The increasing burden of cardiovascular diseases has made it imperative for healthcare systems to adopt cutting-edge vascular graft solutions, thereby driving market growth.

Advancements in Graft Technology and Materials

Technological innovations in the development of vascular grafts have significantly enhanced their performance and adoption. Traditional grafts made from materials like polytetrafluoroethylene (PTFE) and polyethylene terephthalate (PET) are widely used due to their durability and biocompatibility. However, recent advancements in biomaterials and tissue engineering have introduced new graft options, including biologically derived and hybrid grafts, which combine synthetic and biological components. These innovations improve graft patency, reduce complications like infection and graft failure, and promote faster healing. The development of bioengineered grafts has been a significant milestone in vascular surgery. These grafts, designed to mimic natural blood vessels, offer better integration with the patient’s tissue and reduce the risk of immune rejection. Additionally, improvements in minimally invasive vascular graft delivery systems have made surgical procedures less complex, reducing recovery times and hospital stays for patients. As the medical community continues to invest in research and development, the availability of more efficient and reliable grafts will drive the market forward.

Increasing Geriatric Population

The global population is aging at an unprecedented rate, with people over the age of 60 projected to double by 2050, according to the United Nations. The aging population is highly susceptible to vascular diseases due to the natural wear and tear of blood vessels and the cumulative effects of health issues such as hypertension, diabetes, and high cholesterol. Older adults are at greater risk of developing atherosclerosis, aneurysms, and other vascular complications that often require surgical interventions involving vascular grafts. The increase in life expectancy, coupled with the rise in age-related vascular conditions, is expected to boost the demand for vascular grafts. Elderly patients often require durable, biocompatible grafts that can be safely used in complex surgical procedures. The need for advanced graft technology that can reduce the risk of complications in older adults is particularly important, as these patients are more vulnerable to post-surgical complications. Thus, the expanding geriatric population is a key driver of the vascular grafts market, as healthcare providers seek effective solutions to address the growing demand for vascular surgeries.

Shift Towards Minimally Invasive Procedures

The growing preference for minimally invasive surgeries (MIS) in vascular repair and bypass procedures is another key factor driving the vascular grafts market. MIS techniques, such as endovascular aneurysm repair (EVAR) and laparoscopic vascular surgery, offer numerous advantages over traditional open surgeries. These include shorter hospital stays, faster recovery times, reduced scarring, and lower risks of infection. With advancements in imaging technology, surgical instruments, and graft materials, MIS has become more accessible and widespread, further boosting its adoption. Minimally invasive procedures have particularly benefited from the development of flexible, durable, and easily implantable vascular grafts that can be delivered through smaller incisions. In endovascular procedures, for instance, vascular grafts are delivered via catheter-based systems, allowing surgeons to navigate complex anatomy with minimal disruption to surrounding tissues. This trend toward less invasive treatment options has increased patient demand and broadened the scope of vascular graft applications, particularly in patients who are at high risk for complications during traditional surgery. As healthcare systems continue to embrace MIS, the vascular grafts market is set to experience sustained growth.

Market Trends

Increasing Adoption of Bioengineered and Biocompatible Grafts
One of the most prominent trends in the vascular grafts market is the growing adoption of bioengineered and biocompatible grafts. Traditional synthetic grafts, such as those made from polytetrafluoroethylene (PTFE) and Dacron, have been widely used in vascular surgeries for decades. However, recent advancements in biotechnology have led to the development of bioengineered grafts, which combine synthetic materials with biological elements to enhance compatibility with the patient’s body. For instance, companies are now developing grafts that integrate human cells or tissues, mimicking the natural structure and function of blood vessels, thereby improving long-term outcomes. Additionally, grafts that use biodegradable polymers are emerging, offering temporary scaffolding to support vessel healing before being absorbed by the body, eliminating the need for additional surgeries. This shift towards biologically advanced grafts is expected to drive innovation and create new growth opportunities within the market.

Rising Demand for Minimally Invasive Vascular Surgeries
Another key trend shaping the vascular grafts market is the increasing preference for minimally invasive vascular surgeries. Patients and healthcare providers are increasingly opting for minimally invasive techniques, such as endovascular aneurysm repair (EVAR) and percutaneous coronary intervention (PCI), due to their advantages over traditional open surgeries. For instance, advancements in catheter-based systems have made it possible to deploy vascular grafts through smaller incisions, resulting in reduced recovery times, fewer complications, and shorter hospital stays. This trend is particularly significant in the treatment of aneurysms, peripheral artery disease, and vascular occlusions, where the use of minimally invasive grafts can offer better patient outcomes and lower procedural risks. The growing number of elderly patients and the rising incidence of lifestyle-related vascular diseases are further accelerating the shift towards minimally invasive procedures, driving demand for flexible, durable, and easily implantable grafts in the vascular grafts market.

Market Restraints and Challenges

High Cost of Advanced Vascular Grafts and Procedures

One of the significant challenges restraining the growth of the vascular grafts market is the high cost associated with advanced grafts and vascular surgeries. Bioengineered and biocompatible grafts, while offering superior performance and reduced complications, are often more expensive than traditional synthetic grafts. Additionally, the use of minimally invasive procedures such as endovascular aneurysm repair (EVAR) requires sophisticated equipment and highly skilled medical professionals, further driving up healthcare costs. In regions with limited healthcare funding or insufficient insurance coverage, the affordability of such advanced treatments becomes a barrier for patients, limiting the adoption of vascular grafts. This financial burden can also extend to healthcare providers, especially in developing countries, where resources for specialized medical technologies are scarce. The high cost of these procedures and technologies poses a significant challenge to the widespread use of innovative vascular grafts, particularly in price-sensitive markets.

Complications and Risk of Graft Failure

Another key restraint in the vascular grafts market is the potential for complications, including graft failure, infection, and thrombosis. Despite advancements in graft materials and technologies, vascular surgeries still carry inherent risks, especially for patients with pre-existing conditions such as diabetes or chronic kidney disease. These patients are more prone to infections or poor healing post-surgery, leading to higher rates of graft failure. Moreover, issues like restenosis (re-narrowing of the artery) or blood clots can arise after graft implantation, sometimes necessitating further interventions or replacement surgeries. This not only increases healthcare costs but also discourages patients and providers from opting for vascular graft solutions. Addressing these complications requires continued investment in research and development to enhance graft durability and biocompatibility. However, the persistence of such risks continues to present a notable challenge to market growth.

Market Segmentation Analysis

By Product

Vascular grafts serve various critical roles across different medical conditions. Haemodialysis access grafts are essential for patients with kidney failure, providing a reliable access point for long-term dialysis treatments. Endovascular stent grafts, widely utilized in minimally invasive procedures, are effective in treating aneurysms and arterial blockages, offering both flexibility and durability through catheter-based deployment. Coronary artery bypass grafts (CABG) are crucial for bypassing blocked coronary arteries, significantly improving blood flow to the heart in cases of coronary artery disease. For patients with aortic disease, vascular grafts are specifically designed to repair aneurysms and dissections, often using minimally invasive techniques. Peripheral vascular grafts, used in treating peripheral artery disease (PAD), help restore blood flow to limbs affected by severe arterial blockages. Together, these grafts provide essential solutions for various vascular conditions, enhancing patient outcomes through both traditional and minimally invasive approaches.

By Application

Vascular grafts play a critical role in various medical applications, particularly in the treatment of cardiac aneurysms, where they are used to repair high-risk areas like the aorta. Endovascular stent grafts are preferred for minimally invasive procedures, while traditional vascular grafts are used in open surgeries. For kidney failure patients, haemodialysis access grafts offer a long-term solution for dialysis access. Grafts are also essential in treating vascular occlusions, restoring blood flow in blocked coronary and peripheral arteries. Coronary artery bypass grafting (CABG) remains a key application for addressing severe coronary blockages. Additionally, vascular grafts are utilized in other conditions, including trauma-induced vascular damage and congenital abnormalities, further broadening their medical relevance.

Segments

Based on product

Haemodialysis Access Grafts
Endovascular Stent Grafts
Coronary Artery Based on-Pass Grafts
Vascular Grafts for Aorta Disease
Peripheral Vascular Grafts

Based on application

Cardiac Aneurysm
Endovascular Stent Graft
Vascular Graft
Kidney Failure
Vascular Occlusion
Coronary Artery Disease
Others

Based on raw material

Synthetic Vascular Grafts
Polytetrafluoroethylene (PTFE) Grafts
Polyester Grafts,
Polyurethane Grafts
Biological Vascular Grafts
Autografts
Allografts
Xenografts
Hybrid Vascular Grafts

Based on region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Regional Analysis

North America (35%):

North America dominates the global vascular grafts market, accounting for approximately 35% of the total market share. The region’s leadership is attributed to its advanced healthcare infrastructure, a high prevalence of cardiovascular diseases, and the widespread adoption of innovative graft technologies. The rising incidence of lifestyle-related diseases such as hypertension, diabetes, and obesity has increased the demand for vascular graft surgeries. In addition, the presence of key market players and a strong focus on research and development (R&D) contribute to the region’s significant market share. The U.S., in particular, drives growth in North America due to its high healthcare spending and increasing adoption of minimally invasive surgical techniques. The region is expected to continue its leadership position throughout the forecast period, driven by technological advancements and an aging population.

Europe (28%):

Europe holds the second-largest market share, contributing around 28% to the global vascular grafts market. The region’s aging population and increasing prevalence of cardiovascular diseases have driven the demand for vascular grafts. Countries such as Germany, France, and the United Kingdom are major contributors, benefiting from robust healthcare systems and high per capita healthcare expenditure. Additionally, the increasing focus on reducing hospital stays and improving patient outcomes through minimally invasive surgeries is boosting the adoption of vascular grafts in the region. Furthermore, European governments’ investment in healthcare infrastructure and medical technologies supports market growth. The presence of leading medical device companies in Europe also contributes to the development of innovative vascular graft solutions, further enhancing the market’s expansion.

Key players

Medtronic
Terumo Corporation
LeMaitre Vascular, Inc.
Getinge AB
BD (Becton Dickinson)
Abbott
Braun Melsungen AG
L. Gore and Associates, Inc.
MicroPort Scientific Corporation
Endologix

Competitive Analysis

The vascular grafts market is highly competitive, driven by the presence of prominent players such as Medtronic, Terumo Corporation, and LeMaitre Vascular, Inc., which lead in innovation and market share. Companies like Getinge AB and BD (Becton Dickinson) have diversified product portfolios, focusing on enhancing graft durability and biocompatibility. Abbott and B. Braun Melsungen AG are recognized for their strong R&D capabilities and global reach, while W. L. Gore and Associates, Inc. is known for its advanced synthetic grafts. MicroPort Scientific Corporation and Endologix have strengthened their market positions through technological advancements and strategic collaborations. Intense competition among these players is driving continuous innovation in graft materials and minimally invasive technologies, benefiting patients by improving outcomes and reducing recovery times. Each of these companies is focusing on expanding their geographical presence and enhancing product quality to maintain a competitive edge in the market.

Recent Developments

In May 2024, Medtronic is renowned for its Endurant II Stent Graft Systems, widely used in the treatment of abdominal aortic aneurysm.
In May 2023, Terumo Aortic announced FDA approval of the RelayPro Thoracic Stent-Graft device for the treatment of dissection and transection in the United States.
In May 2022, Getinge reached record deliveries of vascular grafts after ramping up production at its La Ciotat factory in France.
March 2024, BD initiated the AGILITY study to evaluate the safety and effectiveness of the BD Vascular Covered Stent for the treatment of Peripheral Arterial Disease (PAD).

In February 2023, Abbott announced the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative atherectomy system.
In January 2024, Gore received FDA approval for a lower profile GORE VIABAHN VBX Balloon Expandable Endoprosthesis.
In April 2024, MicroPort Endovastec completed its first implantation of the Cratos Branched Aortic Stent-Graft System in a pre-market clinical study in the EU and Japan.
In July 2023, Endologix announced the first patients treated with the DETOUR System for complex Peripheral Artery Disease (PAD) since FDA approval.

Market Concentration and Characteristics

The vascular grafts market is moderately concentrated, with a few major players holding significant market shares. Companies like Medtronic, Terumo Corporation, and W. L. Gore and Associates, Inc. dominate the market, driven by their strong product portfolios, extensive research and development efforts, and global presence. The market is characterized by continuous innovation, with a focus on developing advanced materials such as bioengineered and hybrid grafts, which improve biocompatibility and reduce post-surgical complications. Additionally, the market sees a strong emphasis on minimally invasive surgical techniques, further driving product development. Despite the dominance of key players, smaller companies are also making notable advancements, contributing to increased competition and fostering innovation across the sector.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Report Coverage

The research report offers an in-depth analysis based on product, application, raw material and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The development of bioengineered and hybrid grafts will continue to improve biocompatibility and long-term outcomes, driving demand for advanced vascular grafts.
The increasing preference for minimally invasive surgeries, such as endovascular aneurysm repair (EVAR), will fuel the adoption of flexible, durable vascular grafts.
As cardiovascular diseases remain a leading cause of death globally, the need for vascular grafts in treating arterial blockages and aneurysms will surge.
The vascular grafts market will see significant growth in emerging regions like Asia Pacific and Latin America due to improving healthcare infrastructure and increasing healthcare expenditure.
The aging global population will lead to higher demand for vascular grafts, as older adults are more prone to vascular diseases requiring surgical intervention.
The use of synthetic and bioengineered vascular grafts is expected to rise, driven by ongoing innovations that enhance graft longevity and reduce complications.
Companies will continue to invest heavily in research and development to create more advanced graft materials, fueling future product innovations and market expansion.
Key players in the vascular grafts market will engage in collaborations and partnerships to enhance their product portfolios and expand their geographical reach.
Favorable regulatory frameworks will encourage the introduction of innovative graft technologies, facilitating faster approval processes and market entry.
The trend toward personalized healthcare solutions will drive the development of grafts tailored to individual patient needs, enhancing surgical outcomes and patient satisfaction.

CHAPTER NO. 1 , INTRODUCTION 20
1.1.1. Report Description 20
Purpose of the Report 20
USP & Key Offerings 20
1.1.2. Key Benefits for Stakeholders 20
1.1.3. Target Audience 21
1.1.4. Report Scope 21
CHAPTER NO. 2 , EXECUTIVE SUMMARY 22
2.1. Vascular Grafts Market Snapshot 22
2.1.1. Global Vascular Grafts Market, 2018 – 2032 (USD Million) 24
CHAPTER NO. 3 , GEOPOLITICAL CRISIS IMPACT ANALYSIS 25
3.1. Russia-Ukraine and Israel-Palestine War Impacts 25
CHAPTER NO. 4 , VASCULAR GRAFTS MARKET – INDUSTRY ANALYSIS 26
4.1. Introduction 26
4.2. Market Drivers 27
4.2.1. Driving Factor 1 Analysis 27
4.2.2. Driving Factor 2 Analysis 28
4.3. Market Restraints 29
4.3.1. Restraining Factor Analysis 29
4.4. Market Opportunities 30
4.4.1. Market Opportunity Analysis 30
4.5. Porter’s Five Forces Analysis 31
CHAPTER NO. 5 , ANALYSIS COMPETITIVE LANDSCAPE 32
5.1. Company Market Share Analysis – 2023 32
5.1.1. Global Vascular Grafts Market, Company Market Share, Based on Volume, 2023 32
5.1.2. Global Vascular Grafts Market, Company Market Share, Based on Revenue, 2023 33
5.1.3. Global Vascular Grafts Market, Top 6 Company Market Share, Based on Revenue, 2023 33
5.1.4. Global Vascular Grafts Market, Top 3 Company Market Share, Based on Revenue, 2023 34
5.2. Global Vascular Grafts Market Company Revenue Market Share, 2023 35
5.3. Company Assessment Metrics, 2023 36
5.3.1. Stars 36
5.3.2. Emerging Leaders 36
5.3.3. Pervasive Players 36
5.3.4. Participants 36
5.4. Start-ups /SMEs Assessment Metrics, 2023 36
5.4.1. Progressive Companies 36
5.4.2. Responsive Companies 36
5.4.3. Dynamic Companies 36
5.4.4. Starting Blocks 36
5.5. Strategic Developments 37
5.5.1. Acquisitions & Mergers 37
New Product Launch 37
Global Expansion 37
5.6. Key Players Product Matrix 38
CHAPTER NO. 6 , PESTEL & ADJACENT MARKET ANALYSIS 39
6.1. PESTEL 39
6.1.1. Political Factors 39
6.1.2. Economic Factors 39
6.1.3. Social Factors 39
6.1.4. Technological Factors 39
6.1.5. Environmental Factors 39
6.1.6. Legal Factors 39
6.2. Adjacent Market Analysis 39
CHAPTER NO. 7 , VASCULAR GRAFTS MARKET – BASED ON PRODUCT SEGMENT ANALYSIS 40
7.1. Vascular Grafts Market Overview, Based on Product Segment 40
7.1.1. Vascular Grafts Market Revenue Share, Based on Product, 2023 & 2032 41
7.1.2. Vascular Grafts Market Attractiveness Analysis, Based on Product 42
7.1.3. Incremental Revenue Growth Opportunity, Based on Product, 2024 – 2032 42
7.1.4. Vascular Grafts Market Revenue, Based on Product, 2018, 2023, 2027 & 2032 43
7.2. Haemodialysis Access Grafts 44
7.3. Endovascular Stent Grafts 45
7.4. Coronary Artery Based on-Pass Grafts 46
7.5. Vascular Grafts for Aorta Disease 47
7.6. Peripheral Vascular Grafts 48
CHAPTER NO. 8 , VASCULAR GRAFTS MARKET – BASED ON APPLICATION SEGMENT ANALYSIS 49
8.1. Vascular Grafts Market Overview, Based on Application Segment 49
8.1.1. Vascular Grafts Market Revenue Share, Based on Application, 2023 & 2032 50
8.1.2. Vascular Grafts Market Attractiveness Analysis, Based on Application 51
8.1.3. Incremental Revenue Growth Opportunity, Based on Application, 2024 – 2032 51
8.1.4. Vascular Grafts Market Revenue, Based on Application, 2018, 2023, 2027 & 2032 52
8.2. Cardiac Aneurysm 53
8.2.1. Endovascular Stent Graft 53
8.2.2. Vascular Graft 54
8.3. Kidney Failure 55
8.4. Vascular Occlusion 56
8.5. Coronary Artery Disease 57
8.6. Others 58
CHAPTER NO. 9 , VASCULAR GRAFTS MARKET – BASED ON RAW MATERIAL SEGMENT ANALYSIS 59
9.1. Vascular Grafts Market Overview, Based on Raw Material Segment 59
9.1.1. Vascular Grafts Market Revenue Share, Based on Raw Material, 2023 & 2032 60
9.1.2. Vascular Grafts Market Attractiveness Analysis, Based on Raw Material 61
9.1.3. Incremental Revenue Growth Opportunity, Based on Raw Material, 2024 – 2032 61
9.1.4. Vascular Grafts Market Revenue, Based on Raw Material, 2018, 2023, 2027 & 2032 62
9.2. Synthetic Vascular Grafts 63
9.2.1. Polytetrafluoroethylene (PTFE) Grafts 63
9.2.2. Polyester Grafts 64
9.2.3. Polyurethane Grafts 64
9.3. Biological Vascular Grafts 65
9.3.1. Autografts 65
9.3.2. Allografts 66
9.3.3. Xenografts 66
9.4. Hybrid Vascular Grafts 67
CHAPTER NO. 10 , VASCULAR GRAFTS MARKET – GLOBAL ANALYSIS 68
10.1. Product 68
10.1.1. Global Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 68
10.2. Global Vascular Grafts Market Revenue, Based on Product, 2024 – 2032 (USD Million) 68
10.3. Application 69
10.3.1. Global Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 69
10.3.2. Global Vascular Grafts Market Revenue, Based on Application, 2024 – 2032 (USD Million) 69
10.4. Raw Material 70
10.4.1. Global Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 70
10.4.2. Global Vascular Grafts Market Revenue, Based on Raw Material, 2024 – 2032 (USD Million) 70
CHAPTER NO. 11 , VASCULAR GRAFTS MARKET – NORTH AMERICA 71
11.1. North America 71
11.1.1. Key Highlights 71
11.1.2. North America Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 72
11.1.3. North America Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 73
11.1.4. North America Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 74
11.1.5. North America Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 75
11.2. U.S. 76
11.3. Canada 76
11.4. Mexico 76
CHAPTER NO. 12 , VASCULAR GRAFTS MARKET – EUROPE 77
12.1. Europe 77
12.1.1. Key Highlights 77
12.1.2. Europe Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 78
12.1.3. Europe Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 79
12.1.4. Europe Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 80
12.1.5. Europe Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 81
12.2. UK 82
12.3. France 82
12.4. Germany 82
12.5. Italy 82
12.6. Spain 82
12.7. Russia 82
12.8. Belgium 82
12.9. Netherland 82
12.10. Austria 82
12.11. Sweden 82
12.12. Poland 82
12.13. Denmark 82
12.14. Switzerland 82
12.15. Rest of Europe 82
CHAPTER NO. 13 , VASCULAR GRAFTS MARKET – ASIA PACIFIC 83
13.1. Asia Pacific 83
13.1.1. Key Highlights 83
13.1.2. Asia Pacific Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 84
13.1.3. Asia Pacific Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 85
13.1.4. Asia Pacific Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 86
13.1.5. Asia Pacific Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 87
13.2. China 88
13.3. Japan 88
13.4. South Korea 88
13.5. India 88
13.6. Australia 88
13.7. Thailand 88
13.8. Indonesia 88
13.9. Vietnam 88
13.10. Malaysia 88
13.11. Philippines 88
13.12. Taiwan 88
13.13. Rest of Asia Pacific 88
CHAPTER NO. 14 , VASCULAR GRAFTS MARKET – LATIN AMERICA 89
14.1. Latin America 89
14.1.1. Key Highlights 89
14.1.2. Latin America Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 90
14.1.3. Latin America Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 91
14.1.4. Latin America Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 92
14.1.5. Latin America Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 93
14.2. Brazil 94
14.3. Argentina 94
14.4. Peru 94
14.5. Chile 94
14.6. Colombia 94
14.7. Rest of Latin America 94
CHAPTER NO. 15 , VASCULAR GRAFTS MARKET – MIDDLE EAST 95
15.1. Middle East 95
15.1.1. Key Highlights 95
15.1.2. Middle East Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 96
15.1.3. Middle East Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 97
15.1.4. Middle East Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 98
15.1.5. Middle East Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 99
15.2. UAE 100
15.3. KSA 100
15.4. Israel 100
15.5. Turkey 100
15.6. Iran 100
15.7. Rest of Middle East 100
CHAPTER NO. 16 , VASCULAR GRAFTS MARKET – AFRICA 101
16.1. Africa 101
16.1.1. Key Highlights 101
16.1.2. Africa Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 102
16.1.3. Africa Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 103
16.1.4. Africa Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 104
16.1.5. Africa Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 105
16.2. Egypt 106
16.3. Nigeria 106
16.4. Algeria 106
16.5. Morocco 106
16.6. Rest of Africa 106
CHAPTER NO. 17 , COMPANY PROFILES 107
17.1. Medtronic 107
17.1.1. Company Overview 107
17.1.2. Product Portfolio 107
17.1.3. Swot Analysis 107
17.1.4. Business Strategy 108
17.1.5. Financial Overview 108
17.2. Terumo Corporation 109
17.3. Lemaitre Vascular, Inc. 109
17.4. Getinge AB 109
17.5. BD (Becton Dickinson) 109
17.6. Abbott 109
17.7. B. Braun Melungeon AG. 109
17.8. W. L. Gore and Associates, Inc. 109
17.9. Micro Port Scientific Corporation 109
17.10. Endo Logix 109
CHAPTER NO. 18 , RESEARCH METHODOLOGY 110
18.1. Research Methodology 110
18.1.1. Phase I – Secondary Research 111
18.1.2. Phase II – Data Modeling 111
Company Share Analysis Model 112
Revenue Based Modeling 112
18.1.3. Phase III – Primary Research 113
18.1.4. Research Limitations 114
Assumptions 114

List of Figures
FIG NO. 1. Global Vascular Grafts Market Revenue, 2018 – 2032 (USD Million) 23
FIG NO. 2. Porter’s Five Forces Analysis for Global Vascular Grafts Market 30
FIG NO. 3. Company Share Analysis, 2023 31
FIG NO. 4. Company Share Analysis, 2023 32
FIG NO. 5. Company Share Analysis, 2023 32
FIG NO. 6. Company Share Analysis, 2023 33
FIG NO. 7. Vascular Grafts Market – Company Revenue Market Share, 2023 34
FIG NO. 8. Vascular Grafts Market Revenue Share, Based on Product, 2023 & 2032 40
FIG NO. 9. Market Attractiveness Analysis, Based on Product 41
FIG NO. 10. Incremental Revenue Growth Opportunity Based on Product, 2024 – 2032 41
FIG NO. 11. Vascular Grafts Market Revenue, Based on Product, 2018, 2023, 2027 & 2032 42
FIG NO. 12. Global Vascular Grafts Market for Hemodialysis Access Grafts, Revenue (USD Million) 2018 – 2032 43
FIG NO. 13. Global Vascular Grafts Market for Endovascular Stent Grafts, Revenue (USD Million) 2018 – 2032 44
FIG NO. 14. Global Vascular Grafts Market for Coronary Artery Based on-Pass Grafts, Revenue (USD Million) 2018 – 2032 45
FIG NO. 15. Global Vascular Grafts Market for Vascular Grafts for Aorta Disease, Revenue (USD Million) 2018 – 2032 46
FIG NO. 16. Global Vascular Grafts Market for Peripheral Vascular Grafts, Revenue (USD Million) 2018 – 2032 47
FIG NO. 17. Vascular Grafts Market Revenue Share, Based on Application, 2023 & 2032 49
FIG NO. 18. Market Attractiveness Analysis, Based on Application 50
FIG NO. 19. Incremental Revenue Growth Opportunity Based on Application, 2024 – 2032 50
FIG NO. 20. Vascular Grafts Market Revenue, Based on Application, 2018, 2023, 2027 & 2032 51
FIG NO. 21. Global Vascular Grafts Market for Cardiac Aneurysm, Revenue (USD Million) 2018 – 2032 52
FIG NO. 22. Global Vascular Grafts Market for Endovascular Stent Graft, Revenue (USD Million) 2018 – 2032 52
FIG NO. 23. Global Vascular Grafts Market for Vascular Graft, Revenue (USD Million) 2018 – 2032 53
FIG NO. 24. Global Vascular Grafts Market for Kidney Failure, Revenue (USD Million) 2018 – 2032 54
FIG NO. 25. Global Vascular Grafts Market for Vascular Occlusion, Revenue (USD Million) 2018 – 2032 55
FIG NO. 26. Global Vascular Grafts Market for Coronary Artery Disease, Revenue (USD Million) 2018 – 2032 56
FIG NO. 27. Global Vascular Grafts Market for Others, Revenue (USD Million) 2018 – 2032 57
FIG NO. 28. Vascular Grafts Market Revenue Share, Based on Raw Material, 2023 & 2032 59
FIG NO. 29. Market Attractiveness Analysis, Based on Raw Material 60
FIG NO. 30. Incremental Revenue Growth Opportunity Based on Raw Material, 2024 – 2032 60
FIG NO. 31. Vascular Grafts Market Revenue, Based on Raw Material, 2018, 2023, 2027 & 2032 61
FIG NO. 32. Global Vascular Grafts Market for Synthetic Vascular Grafts, Revenue (USD Million) 2018 – 2032 62
FIG NO. 33. Global Vascular Grafts Market for Polytetrafluoroethylene (PTFE) Grafts, Revenue (USD Million) 2018 – 2032 62
FIG NO. 34. Global Vascular Grafts Market for Polyester Grafts, Revenue (USD Million) 2018 – 2032 63
FIG NO. 35. Global Vascular Grafts Market for Polyurethane Graft, Revenue (USD Million) 2018 – 2032 63
FIG NO. 36. Global Vascular Grafts Market for Biological Vascular Grafts, Revenue (USD Million) 2018 – 2032 64
FIG NO. 37. Global Vascular Grafts Market for Autografts. Revenue (USD Million) 2018 – 2032 64
FIG NO. 38. Global Vascular Grafts Market for Allografts, Revenue (USD Million) 2018 – 2032 65
FIG NO. 39. Global Vascular Grafts Market for Xenografts, Revenue (USD Million) 2018 – 2032 65
FIG NO. 40. Global Vascular Grafts Market for Hybrid Vascular Grafts, Revenue (USD Million) 2018 – 2032 66
FIG NO. 41. North America Vascular Grafts Market Revenue, 2018 – 2032 (USD Million) 70
FIG NO. 42. Europe Vascular Grafts Market Revenue, 2018 – 2032 (USD Million) 76
FIG NO. 43. Asia Pacific Vascular Grafts Market Revenue, 2018 – 2032 (USD Million) 82
FIG NO. 44. Latin America Vascular Grafts Market Revenue, 2018 – 2032 (USD Million) 88
FIG NO. 45. Middle East Vascular Grafts Market Revenue, 2018 – 2032 (USD Million) 94
FIG NO. 46. Africa Vascular Grafts Market Revenue, 2018 – 2032 (USD Million) 100
FIG NO. 47. Research Methodology – Detailed View 109
FIG NO. 48. Research Methodology 110

List of Tables
TABLE NO. 1. , Global Vascular Grafts Market, Snapshot 20
TABLE NO. 2. , Drivers for the Vascular Grafts Market, Impact Analysis 25
TABLE NO. 3. , Restraints for the Vascular Grafts Market, Impact Analysis 27
TABLE NO. 4. , Global Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 66
TABLE NO. 5. , Global Vascular Grafts Market Revenue, Based on Product, 2024 – 2032 (USD Million) 66
TABLE NO. 6. , Global Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 67
TABLE NO. 7. , Global Vascular Grafts Market Revenue, Based on Application, 2024 – 2032 (USD Million) 67
TABLE NO. 8. , Global Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 68
TABLE NO. 9. , Global Vascular Grafts Market Revenue, Based on Raw Material, 2024 – 2032 (USD Million) 68
TABLE NO. 10. , North America Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 70
TABLE NO. 11. , North America Vascular Grafts Market Revenue, Based on Country, 2024 – 2032 (USD Million) 70
TABLE NO. 12. , North America Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 71
TABLE NO. 13. , North America Vascular Grafts Market Revenue, Based on Product, 2024 – 2032 (USD Million) 71
TABLE NO. 14. , North America Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 72
TABLE NO. 15. , North America Vascular Grafts Market Revenue, Based on Application, 2024 – 2032 (USD Million) 72
TABLE NO. 16. , North America Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 73
TABLE NO. 17. , North America Vascular Grafts Market Revenue, Based on Raw Material, 2024 – 2032 (USD Million) 73
TABLE NO. 18. , Europe Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 76
TABLE NO. 19. , Europe Vascular Grafts Market Revenue, Based on Country, 2024 – 2032 (USD Million) 76
TABLE NO. 20. , Europe Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 77
TABLE NO. 21. , Europe Vascular Grafts Market Revenue, Based on Product, 2024 – 2032 (USD Million) 77
TABLE NO. 22. , Europe Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 78
TABLE NO. 23. , Europe Vascular Grafts Market Revenue, Based on Application, 2024 – 2032 (USD Million) 78
TABLE NO. 24. , Europe Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 79
TABLE NO. 25. , Europe Vascular Grafts Market Revenue, Based on Raw Material, 2024 – 2032 (USD Million) 79
TABLE NO. 26. , Asia Pacific Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 82
TABLE NO. 27. , Asia Pacific Vascular Grafts Market Revenue, Based on Country, 2024 – 2032 (USD Million) 82
TABLE NO. 28. , Asia Pacific Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 83
TABLE NO. 29. , Asia Pacific Vascular Grafts Market Revenue, Based on Product, 2024 – 2032 (USD Million) 83
TABLE NO. 30. , Asia Pacific Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 84
TABLE NO. 31. , Asia Pacific Vascular Grafts Market Revenue, Based on Application, 2024 – 2032 (USD Million) 84
TABLE NO. 32. , Asia Pacific Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 85
TABLE NO. 33. , Asia Pacific Vascular Grafts Market Revenue, Based on Raw Material, 2024 – 2032 (USD Million) 85
TABLE NO. 34. , Latin America Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 88
TABLE NO. 35. , Latin America Vascular Grafts Market Revenue, Based on Country, 2024 – 2032 (USD Million) 88
TABLE NO. 36. , Latin America Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 89
TABLE NO. 37. , Latin America Vascular Grafts Market Revenue, Based on Product, 2024 – 2032 (USD Million) 89
TABLE NO. 38. , Latin America Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 90
TABLE NO. 39. , Latin America Vascular Grafts Market Revenue, Based on Application, 2024 – 2032 (USD Million) 90
TABLE NO. 40. , Latin America Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 91
TABLE NO. 41. , Latin America Vascular Grafts Market Revenue, Based on Raw Material, 2024 – 2032 (USD Million) 91
TABLE NO. 42. , Middle East Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 94
TABLE NO. 43. , Middle East Vascular Grafts Market Revenue, Based on Country, 2024 – 2032 (USD Million) 94
TABLE NO. 44. , Middle East Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 95
TABLE NO. 45. , Middle East Vascular Grafts Market Revenue, Based on Product, 2024 – 2032 (USD Million) 95
TABLE NO. 46. , Middle East Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 96
TABLE NO. 47. , Middle East Vascular Grafts Market Revenue, Based on Application, 2024 – 2032 (USD Million) 96
TABLE NO. 48. , Middle East Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 97
TABLE NO. 49. , Middle East Vascular Grafts Market Revenue, Based on Raw Material, 2024 – 2032 (USD Million) 97
TABLE NO. 50. , Africa Vascular Grafts Market Revenue, Based on Country, 2018 – 2023 (USD Million) 100
TABLE NO. 51. , Africa Vascular Grafts Market Revenue, Based on Country, 2024 – 2032 (USD Million) 100
TABLE NO. 52. , Africa Vascular Grafts Market Revenue, Based on Product, 2018 – 2023 (USD Million) 101
TABLE NO. 53. , Africa Vascular Grafts Market Revenue, Based on Product, 2024 – 2032 (USD Million) 101
TABLE NO. 54. , Africa Vascular Grafts Market Revenue, Based on Application, 2018 – 2023 (USD Million) 102
TABLE NO. 55. , Africa Vascular Grafts Market Revenue, Based on Application, 2024 – 2032 (USD Million) 102
TABLE NO. 56. , Africa Vascular Grafts Market Revenue, Based on Raw Material, 2018 – 2023 (USD Million) 103
TABLE NO. 57. , Africa Vascular Grafts Market Revenue, Based on Raw Material, 2024 – 2032 (USD Million) 103

Frequently Asked Questions:

What is the projected market size of the vascular grafts market in 2023 and 2032, and what is the CAGR?

The vascular grafts market is expected to grow from USD 1,263.48 million in 2023 to USD 2,422.39 million by 2032, with a CAGR of 7.50% from 2024 to 2032.

What are the main drivers of growth in the vascular grafts market?

Key drivers include the rising prevalence of cardiovascular diseases, technological advancements in graft materials, and increasing demand for minimally invasive surgeries.

Which region holds the largest share in the vascular grafts market?

North America holds the largest market share, driven by advanced healthcare infrastructure and a high prevalence of cardiovascular diseases.

What role do bioengineered grafts play in the vascular grafts market?

Bioengineered grafts enhance graft biocompatibility, reduce complications, and improve long-term outcomes, making them increasingly popular in vascular surgeries.

Why is the demand for minimally invasive vascular procedures increasing?

Minimally invasive procedures offer advantages such as shorter recovery times, reduced hospital stays, and fewer complications, driving their growing demand in vascular surgeries.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –